Osteoclast Cancer Cell Metabolic Cross-talk Confers PARP Inhibitor Resistance in Bone Metastatic Breast Cancer.

已完结 10 由仰望星空发布于 2025/1/13 22:49:39

DOI:10.1158/0008-5472.CAN-23-1443
作者：Huijuan Fan,?Zhanao Xu,?Ke Yao,?Bingxin Zheng,?Yuan Zhang,?Xuxiang Wang,?Tengjiang Zhang,?Xuan Li,?Haitian Hu,?Bin Yue,?Zeping Hu,?Hanqiu Zheng
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1158/0008-5472.CAN-23-1443

American Association for Cancer Research (AACR)

Abstract：The majority of patients with late-stage breast cancer develop distal bone metastases. The bone microenvironment can affect response to therapy, and uncovering the underlying mechanisms coul

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureEutectic molecule ligand stabilizes photoactive black phase perovskite